Protagonist Therapeutics (PTGX) Earnings
|
Expand Research on PTGX
| Next EPS Date | 5/1/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +10.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +25.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/1/24 | Q124 | N/A | $1.19 | N/A | N/A | $120M | N/A | N/A | N/A | ||
| 2/27/24 | Q423 | N/A | -$0.14 | N/A | $60M | $40M | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.70 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/9/23 | Q223 | N/A | -$0.65 | N/A | N/A | N/A | N/A | N/A | N/A | ||
8/3/23  |
Q223 | -$0.68 | -$0.65 | -$0.03 | N/A | N/A | N/A |  | | Details | |
| 5/10/23 | Q123 | N/A | -$0.73 | N/A | N/A | $2.5M | N/A | N/A | N/A | ||
| 3/8/23 | Q422 | N/A | -$0.64 | N/A | N/A | $6M | N/A | N/A | N/A | ||
| 11/8/22 | Q322 | -$0.70 | -$0.91 | +$0.21 | $10.29M | $225K | N/A | | | Details |
